A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
The objective of this Phase 1 study is to evaluate the VISION5 Product's safety and efficacy.
Inclusion Criteria:
Exclusion Criteria:
Contact ForSight Vision5 For Trial Locations, Latvia